Immunomodulatory therapeutic proteins in COVID‐19: current clinical development and clinical pharmacology considerations
P Ji, J Chen, A Golding, NP Nikolov… - The Journal of …, 2020 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19) pandemic caused by infection with
SARS‐CoV‐2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
SARS‐CoV‐2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
Immunomodulatory Therapeutic Proteins in COVID‐19: Current Clinical Development and Clinical Pharmacology Considerations.
P Ji, J Chen, A Golding, NP Nikolov… - Journal of Clinical …, 2020 - search.ebscohost.com
Abstract The coronavirus disease 2019 (COVID‐19) pandemic caused by infection with
SARS‐CoV‐2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
SARS‐CoV‐2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
Immunomodulatory Therapeutic Proteins in COVID‐19: Current Clinical Development and Clinical Pharmacology Considerations
P Ji, J Chen, A Golding, NP Nikolov, B Saluja… - The Journal of Clinical …, 2020 - infona.pl
The coronavirus disease 2019 (COVID‐19) pandemic caused by infection with SARS‐CoV‐
2 has led to more than 600 000 deaths worldwide. Patients with severe disease often …
2 has led to more than 600 000 deaths worldwide. Patients with severe disease often …
Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations
P Ji, J Chen, A Golding, NP Nikolov… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) pandemic caused by infection with SARS-CoV-2
has led to more than 600 000 deaths worldwide. Patients with severe disease often …
has led to more than 600 000 deaths worldwide. Patients with severe disease often …
[HTML][HTML] Immunomodulatory Therapeutic Proteins in COVID‐19: Current Clinical Development and Clinical Pharmacology Considerations
P Ji, J Chen, A Golding, NP Nikolov… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID‐19) pandemic caused by infection with
SARS‐CoV‐2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
SARS‐CoV‐2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
Immunomodulatory therapeutic proteins in COVID-19: current clinical development and clinical pharmacology considerations.
P Ji, J Chen, A Golding, NP Nikolov, B Saluja, YR Ren… - 2020 - cabidigitallibrary.org
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by infection with
SARS-CoV-2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
SARS-CoV-2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations.
P Ji, J Chen, A Golding, NP Nikolov… - Journal of Clinical …, 2020 - europepmc.org
Abstract The coronavirus disease 2019 (COVID‐19) pandemic caused by infection with
SARS‐CoV‐2 has led to more than 600 000 deaths worldwide. Patients with severe disease …
SARS‐CoV‐2 has led to more than 600 000 deaths worldwide. Patients with severe disease …